Formamide

Formamide

SCHEMBL9729793

NC=O.ONCC1=Cc2cc(OCC3CCCCC3)ccc2OC1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 9/20 0.64
MTNR1A P48039 2/20 0.47
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
PARP10 Q53GL7 5/20 0.40
PARP15 Q460N3 4/20 0.40
MAPK1 P28482 1/20 0.40
ALOX12 P18054 1/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formamide SCHEMBL9729701 0.81 ALOX5 (0.62) ALOX5MTNR1AMAOAMAOBALOX12
Urea SCHEMBL9730233 0.79 MTNR1A (0.68) ALOX5MTNR1AMAOBMAPK1ALOX12
Formamide SCHEMBL9729455 0.79 ALOX5 (0.60) ALOX5MTNR1AALOX12PTGS1PTGS2
SCHEMBL9729789 0.78 ALOX5 (1.00) ALOX5ALOX12PTGS1PTGS2
Formamide SCHEMBL9729662 0.78 ALOX5 (0.64) ALOX5MTNR1AMAOAMAOBALOX12
SCHEMBL18031752 0.78 ALOX5 (0.53) ALOX5MTNR1AALOX12
Formamide SCHEMBL9730206 0.77 ALOX5 (0.61) ALOX5MTNR1AALOX12PTGS1PTGS2
Formamide SCHEMBL9729640 0.75 ALDH1A1 (0.53) ALOX5MTNR1AMAPK1
Formamide SCHEMBL9729746 0.75 ALOX5 (0.63) ALOX5MTNR1AALOX12PTGS1PTGS2
Formamide SCHEMBL9729960 0.75 ALOX5 (0.56) ALOX5MTNR1AMAOBALOX12PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155130-A Lipoxygenase inhibitors CIBA-GEIGY CORPORATION (US) 1992-10-13 US disclosed
EP-0412939-A2 Certain benzopyran and benzothiopyran derivatives CIBA-GEIGY AG (CH) 1991-02-13 EP disclosed